- Home
- Products and Markets
- Pharmaceuticals
- Film Coatings
- Immediate Release
- Opadry® amb II
Opadry® amb II High Performance Moisture Barrier Film Coating
Opadry amb II, high performance moisture barrier film coating, is the first fully formulated PVA-based immediate release system without polyethylene glycol (PEG) that delivers the three-fold advantage of high productivity, low impurity levels and a superior tablet finish. Tablets coated with Opadry amb II exhibit a high-gloss, quality appearance with well-defined logos.
The Perfect Balance – Protection, Time Savings, Ease-of-Use
|
Product Literature
General Information Product Process Parameters Product Recon Sheet Product Brochure Published Posters Published White Papers / ArticlesGeneral Information
Impact of Moisture Barrier Film Coating on Stability of Amoxicillin / Clavulanic Acid Tablets
View and Download Send by EmailA packaging case study of in-use product integrity for tablets coated with Opadry amb II.
Product Process Parameters
Opadry® amb II - Clear - Coating Parameters
View and Download Send by EmailStarting process recommendations for use of Opadry amb II clear formulations.
Opadry® amb II - Pigmented - Coating Parameters
View and Download Send by EmailStarting process recommendations for use of Opadry amb II pigmented or white formulations.
Product Recon Sheet
Opadry® amb II Clear - Reconstitution
View and Download Send by EmailMixing procedure and holding instructions for Opadry amb II clear coating formulations.
Opadry® amb II Pigmented - Reconstitution
View and Download Send by EmailMixing procedure and holding instructions for Opadry amb II pigmented and white coating formulations.
Product Brochure
Opadry® amb II Product Information Brochure
View and Download Send by EmailIntroduction to Opadry amb II - aqueous fully formulated PEG-free immediate release system delivering the three-fold advantage of high productivity, low impurity levels and a superior tablet finish.
Published Posters
AAPS 2014 - A Novel Method to Evaluate On-tablet Moisture Barrier Performance of Opadry® Film Coating Systems
View and Download Send by EmailUse of dynamic vapor sorption (DVS) methodology to study the on tablet moisture barrier performance of four IR moisture barrier film coating systems including results on the influence of various coating weight gains.
AAPS 2014 - Evaluation of a Novel, PEG-free, Immediate Release Opadry® Aqueous Moisture Barrier Film Coating with High Productivity
View and Download Send by EmailCharacterization of the properties of ibuprofen tablets coated with a novel, polyethylene glycol (PEG)-free, fully formulated immediate release, moisture barrier film coating system.
AAPS 2016 Utilization of a Moisture Barrier Film Coating to Enhance In-Use Tablet Stability
View and Download Send by EmailStudy demonstrating the detrimental effects of even short-term exposure to the environment on the assay of clavulanic acid, after removal of tablets from their original package.
AAPS 2020 - Evaluation of Different Opadry® Film Coating Systems on Tablets Containing Amorphous Solid Dispersion of Itraconazole
View and Download Send by EmailDVS Symposium 2018 - A Novel Method to Evaluate Moisture Barrier Performance of Opadry® Film Coating Systems On-Tablet
View and Download Send by EmailPublished White Papers / Articles
"Cover Up" - Advances in Film Coating
View and Download Send by EmailThis article is taken from Innovations in Pharmaceutical Technology, March 2015 issue, pages 44-47.
Protection Beyond the Packaging
View and Download Send by EmailProtect moisture sensitive actives from all possible threats to quality and efficacy. As seen in Pharmaceutical Manufacturing and Packing Sourcer, August 2016, pages 42-46, © Samedan Ltd.
Approved for Pharmaceutical Use
- Suitable for use in major pharmaceutical markets and developed using compendial ingredients that meet the regulatory requirements of the user, regionally or globally.
Platform Solutions
Colorcon can help to reduce your project time by providing the right solution through excipient selection and process guidance.
Productivity
Lower total cost and reduce time to market
Dissolution Design
Life cycle management through modified delivery profiles and product line extensions
Patient Adherence
Reduce medication errors and improve patient adherence
Stability
Stable and consistent product performance
Product Authentication
Track and trace